BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+22.37%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$3.64B
AUM Growth
+$3.64B
Cap. Flow
-$639M
Cap. Flow %
-17.56%
Top 10 Hldgs %
62.29%
Holding
72
New
2
Increased
4
Reduced
13
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
THRD
26
DELISTED
Third Harmonic Bio
THRD
$41.2M 1.13%
4,365,933
ENGN icon
27
enGene Holdings
ENGN
$249M
$38.2M 1.05%
2,251,037
NAMS icon
28
NewAmsterdam Pharma
NAMS
$2.8B
$36M 0.99%
1,521,948
GPCR icon
29
Structure Therapeutics
GPCR
$1.14B
$34.8M 0.96%
812,988
ROIV icon
30
Roivant Sciences
ROIV
$8.6B
$28.9M 0.79%
2,742,409
CBIO
31
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$28.6M 0.79%
9,544,262
TCRX icon
32
TScan Therapeutics
TCRX
$106M
$23.7M 0.65%
2,989,474
ALLK
33
DELISTED
Allakos
ALLK
$20.9M 0.57%
16,552,417
+8,000,000
+94% +$10.1M
VSTM icon
34
Verastem
VSTM
$585M
$19.9M 0.55%
1,685,219
CALT
35
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$16.2M 0.45%
750,000
CTMX icon
36
CytomX Therapeutics
CTMX
$350M
$14.4M 0.4%
6,595,801
ELEV
37
DELISTED
Elevation Oncology
ELEV
$11.9M 0.33%
2,312,200
OVID icon
38
Ovid Therapeutics
OVID
$94.6M
$11.8M 0.32%
3,853,818
-2,997,233
-44% -$9.14M
IMUX icon
39
Immunic
IMUX
$79.4M
$11.8M 0.32%
+8,902,972
New +$11.8M
VTGN icon
40
VistaGen Therapeutics
VTGN
$113M
$10.6M 0.29%
2,000,000
ELDN icon
41
Eledon Pharmaceuticals
ELDN
$155M
$8.91M 0.25%
4,326,710
VERV
42
DELISTED
Verve Therapeutics
VERV
$8.63M 0.24%
650,000
IMA
43
ImageneBio, Inc. Common Stock
IMA
$153M
$6.77M 0.19%
4,769,164
CDTX icon
44
Cidara Therapeutics
CDTX
$1.61B
$6.31M 0.17%
6,861,127
VIGL
45
DELISTED
Vigil Neuroscience
VIGL
$6.18M 0.17%
1,813,633
DCTH icon
46
Delcath Systems
DCTH
$381M
$5.73M 0.16%
1,202,067
+225,918
+23% +$1.08M
UNCY icon
47
Unicycive Therapeutics
UNCY
$75.8M
$4.98M 0.14%
3,611,601
+1,493,462
+71% +$2.06M
ENGNW icon
48
enGene Holdings Inc. Warrants
ENGNW
$7.29M
$4.92M 0.14%
945,402
SABS icon
49
SAB Biotherapeutics
SABS
$21.6M
$4.17M 0.11%
917,826
-8,260,456
-90% -$9
LXRX icon
50
Lexicon Pharmaceuticals
LXRX
$392M
$4.05M 0.11%
1,686,924
-22,748,708
-93% -$54.6M